Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?

doi:10.4254/wjh.v7.i3.521

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11765)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-7) series.

Item

Count

PDF

620

WORD

360

HTML

6183

Figures (1-6)

451

Tables (1-7)

245

Sum=7859

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

741

Download

1022

Sum=1763

Publishing Process of This Article

Item

Count

Browse

1004

Download

1139

Sum=2143

Mar 27, 2015 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Mar 27, 2015; 7(3): 521-531
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.521

Table 1 Overall survival in a cohort of 153 patients treated by TACE using the HAP score with a cut-off value of: 0 (HAP A) vs 1 (HAP B) vs 2 (HAP C) vs > 2 (HAP D)

HAP	HAP A(n = 46)	HAP B(n = 43)	HAP C(n = 49)	HAP D(n = 15)
Median-survival, mo (95%CI)	31 (25-37)	31 (20-51)	22 (17-25)	18 (6-32)
P value	0.0454

HAP: Hepatoma arterial-embolization prognostic; TACE: Transarterial chemoembolization.

Citation: Adhoute X, Penaranda G, Castellani P, Perrier H, Bourliere M. Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system? World J Hepatol 2015; 7(3): 521-531
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/521.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i3.521